VasQ External Support for Arteriovenous Fistula

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.

Also called NCT03242343

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (enrolled count) (from the registry)
Sponsor
Laminate Medical Technologies (from the registry)
Registry
  • NCT NCT03242343
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03242343. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-29 (actual); primary completion 2020-10-08 (actual). Results posted on 2026-05-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VasQ External Support for Arteriovenous Fistula
Condition
Arterio-Venous Fistula
Condition
ESRD
Condition
Steal Syndrome
Condition
Aneurysm
Condition
Renal Failure
Condition
Renal Disease
Condition
Diabetes Mellitus
Condition
Kidney Failure
Intervention (Device)
VasQ
Lead sponsor
Laminate Medical Technologies (class: industry)

Record details

Record id
cardio:ct-nct03242343
Content hash
e9059d2537c667098c60afb25a514c4775ef6f8dd0fcb9a97929a604b5144400